Ultragenyx Pharmaceutical (RARE) Prepaid Assets (2016 - 2025)
Ultragenyx Pharmaceutical has reported Prepaid Assets over the past 11 years, most recently at $61.0 million for Q4 2025.
- Quarterly Prepaid Assets rose 52.5% to $61.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.0 million through Dec 2025, up 52.5% year-over-year, with the annual reading at $61.0 million for FY2025, 52.5% up from the prior year.
- Prepaid Assets was $61.0 million for Q4 2025 at Ultragenyx Pharmaceutical, up from $53.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $77.5 million in Q2 2022 and troughed at $40.0 million in Q4 2024.
- The 5-year median for Prepaid Assets is $61.1 million (2025), against an average of $59.2 million.
- Year-over-year, Prepaid Assets plummeted 35.15% in 2023 and then soared 52.5% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $71.7 million in 2021, then dropped by 3.93% to $68.9 million in 2022, then crashed by 30.92% to $47.6 million in 2023, then dropped by 15.99% to $40.0 million in 2024, then surged by 52.5% to $61.0 million in 2025.
- Per Business Quant, the three most recent readings for RARE's Prepaid Assets are $61.0 million (Q4 2025), $53.2 million (Q3 2025), and $61.2 million (Q2 2025).